151 related articles for article (PubMed ID: 20823807)
1. Modern nuclear medicine evaluation of neuroblastoma.
Pflüger T; Schmid I; Coppenrath E; Weiss M
Q J Nucl Med Mol Imaging; 2010 Aug; 54(4):389-400. PubMed ID: 20823807
[TBL] [Abstract][Full Text] [Related]
2. Neuroblastoma: MIBG Imaging and New Tracers.
Pfluger T; Piccardo A
Semin Nucl Med; 2017 Mar; 47(2):143-157. PubMed ID: 28237003
[TBL] [Abstract][Full Text] [Related]
3. Nuclear medicine and multimodality imaging of pediatric neuroblastoma.
Mueller WP; Coppenrath E; Pfluger T
Pediatr Radiol; 2013 Apr; 43(4):418-27. PubMed ID: 23151727
[TBL] [Abstract][Full Text] [Related]
4. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
Kushner BH; Yeung HW; Larson SM; Kramer K; Cheung NK
J Clin Oncol; 2001 Jul; 19(14):3397-405. PubMed ID: 11454888
[TBL] [Abstract][Full Text] [Related]
5. Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy.
Boubaker A; Bischof Delaloye A
Q J Nucl Med; 2003 Mar; 47(1):31-40. PubMed ID: 12714952
[TBL] [Abstract][Full Text] [Related]
6. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
7. Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.
Taggart D; Dubois S; Matthay KK
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):403-18. PubMed ID: 19088694
[TBL] [Abstract][Full Text] [Related]
8. 124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma.
Cistaro A; Quartuccio N; Caobelli F; Piccardo A; Paratore R; Coppolino P; Sperandeo A; Arnone G; Ficola U
Nucl Med Rev Cent East Eur; 2015; 18(2):102-6. PubMed ID: 26315872
[TBL] [Abstract][Full Text] [Related]
9. PET/CT imaging in neuroblastoma.
Piccardo A; Lopci E; Conte M; Foppiani L; Garaventa A; Cabria M; Villavecchia G; Fanti S; Cistaro A
Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):29-39. PubMed ID: 23474633
[TBL] [Abstract][Full Text] [Related]
10. Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.
Matthay KK; Shulkin B; Ladenstein R; Michon J; Giammarile F; Lewington V; Pearson AD; Cohn SL
Br J Cancer; 2010 Apr; 102(9):1319-26. PubMed ID: 20424613
[TBL] [Abstract][Full Text] [Related]
11. Case report of PET/CT imaging of a patient with neuroblastoma using 18F-FPBG.
Suh M; Park HJ; Choi HS; So Y; Lee BC; Lee WW
Pediatrics; 2014 Dec; 134(6):e1731-4. PubMed ID: 25422010
[TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97.
Schmidt M; Simon T; Hero B; Schicha H; Berthold F
Eur J Cancer; 2008 Jul; 44(11):1552-8. PubMed ID: 18424129
[TBL] [Abstract][Full Text] [Related]
13. Current Status and Future Perspective on Molecular Imaging and Treatment of Neuroblastoma.
Feng L; Li S; Wang C; Yang J
Semin Nucl Med; 2023 Jul; 53(4):517-529. PubMed ID: 36682980
[TBL] [Abstract][Full Text] [Related]
14. The new international neuroblastoma response criteria.
Orr KE; McHugh K
Pediatr Radiol; 2019 Oct; 49(11):1433-1440. PubMed ID: 31620844
[TBL] [Abstract][Full Text] [Related]
15. Nuclear medicine imaging of pheochromocytoma and neuroblastoma.
Sisson JC; Shulkin BL
Q J Nucl Med; 1999 Sep; 43(3):217-23. PubMed ID: 10568137
[TBL] [Abstract][Full Text] [Related]
16. Role of MR imaging and iodine 123 MIBG scintigraphy in staging of pediatric neuroblastoma.
Hahn K; Charron M; Shulkin BL
Radiology; 2003 Jun; 227(3):908; author reply 908-9. PubMed ID: 12773693
[No Abstract] [Full Text] [Related]
17. Comparison of diagnosing and staging accuracy of PET (CT) and MIBG on patients with neuroblastoma: Systemic review and meta-analysis.
Xia J; Zhang H; Hu Q; Liu SY; Zhang LQ; Zhang A; Zhang XL; Wang YQ; Liu AG
J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):649-660. PubMed ID: 29058276
[TBL] [Abstract][Full Text] [Related]
18. [Metaiodobenzylguanidine scintigraphy in the diagnosis and followup of neuroblastoma. Apropos of 16 cases].
Hammami H; Hassine L; Mhiri A; Sellem A; Oubich F; Gharssallah L; Barsaoui S; Ben Brahim H
Tunis Med; 2007 May; 85(5):413-6. PubMed ID: 17657930
[TBL] [Abstract][Full Text] [Related]
19. Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
Park JR; Bagatell R; Cohn SL; Pearson AD; Villablanca JG; Berthold F; Burchill S; Boubaker A; McHugh K; Nuchtern JG; London WB; Seibel NL; Lindwasser OW; Maris JM; Brock P; Schleiermacher G; Ladenstein R; Matthay KK; Valteau-Couanet D
J Clin Oncol; 2017 Aug; 35(22):2580-2587. PubMed ID: 28471719
[TBL] [Abstract][Full Text] [Related]
20. Pediatrics: diagnosis of neuroblastoma.
Sharp SE; Gelfand MJ; Shulkin BL
Semin Nucl Med; 2011 Sep; 41(5):345-53. PubMed ID: 21803184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]